Viewing Study NCT00235820


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2025-12-26 @ 3:17 AM
Study NCT ID: NCT00235820
Status: COMPLETED
Last Update Posted: 2008-07-17
First Post: 2005-10-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Sponsor: Abbott
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Psoriasis View
None adalimumab View